metformin and semaglutide provides superior neuroprotective potential compared to in preventing diabetes-associated Alzheimer's disease via dual actions Dr. Charles Mok discusses the

doi:10.1056/NEJMoa2410027 206

Clin Pharmacokinet 2012;51:553-72

With a molecular weight of approximately 625.36 g/mol, ipamorelin operates in a physiological capacity akin to endogenously produced hormone-releasing peptides

doi:10.1177/0884533613491982

PTRS Spotlight: The Best-Positioned Bet Isnt Oral When we apply Intelligencias PTRS (Probability of Technical and Regulatory Success) framework, the most promising GLP-1adjacent asset that is not already approved is CagriSemaa fixed-dose combination of cagrilintide (amylin analogue) and semaglutide, delivered as a once-weekly subcutaneous injection

Icons for the figures were created using BioRender